# Xerion Healthcare

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/xerion-healthcare

- Industry: Healthcare
- Headquarters: UK
- Website: www.xerionhealthcare.co.uk
- Total disclosed funding: $1.2M
- Latest round: Series A (Aug 19, 2015)
- Investors on record: 1

## About

Xerion Healthcare Limited specializes in innovative healthcare solutions, focusing on delivering tailored products and services to enhance operational efficiency across various sectors.Founded in 2015 in the UK, Xerion Healthcare Limited provides healthcare solutions aimed at addressing critical challenges in the industry. The company has undergone no notable pivots or changes in strategy since its inception. Gareth Wakefield is the CEO, leading the firm as it secured Series A funding of GBP 750 thousand from Parkwalk Advisors in August 2015, which has brought the total amount raised to GBP 750 thousand and the current company valuation to GBP 1.96 million.Xerion Healthcare offers a range of innovative healthcare solutions tailored to meet the needs of its diverse client base. Its core product offerings focus on healthcare management systems designed to address key challenges within the healthcare industry. These products enhance operational efficiency and support growth for healthcare providers, particularly within the UK market and other geographical regions.The revenue generation for Xerion Healthcare is primarily structured around direct-to-consumer and B2B transactions. Clients engage in partnerships that ensure a seamless experience through the delivery of its healthcare solutions. Specific pricing plans are established for their flagship products, catering to a broad spectrum of customer needs, allowing the firm to foster long-term client relationships and build a stable financial foundation.Xerion Healthcare plans to leverage the recent Series A funding of GBP 750 thousand to develop new healthcare management products, with expected launches in the upcoming year. The firm aims to expand into European markets, including Germany and France, by 2025. The funding will support product development and market entry strategies to enhance its presence in these targeted regions.

## Funding rounds

- Series A, Aug 19, 2015, $1.2M — Parkwalk Advisors

## Investors

- Parkwalk Advisors (https://capitalatlas.ai/funds/parkwalk-advisors) — Series A